Gambaran Umum
Qiagen N.V., headquartered in Venlo, the Netherlands, is a prominent global provider in the field of Sample to Insight solutions, primarily serving the molecular diagnostics and life sciences industries. The company specializes in developing and commercializing a broad array of products, including sample and assay technologies, for extracting, isolating, and preparing DNA, RNA, and proteins from biological samples for analysis. A key focus of Qiagen's operations is the advancement of molecular diagnostics, with significant investment in technologies that facilitate disease prevention, more precise diagnoses, and personalized healthcare. Qiagen's projects typically emphasize solutions for infectious disease testing and detection of genetic variations, supporting research in areas such as oncology, human identification, and genetic disorders.
Skor Kualitas, Nilai, dan Momentum
Kartu ini menunjukkan skor Kualitas, Nilai, dan Momentum untuk perusahaan tersebut.
Laporan Laba Rugi: Pendapatan, Laba Operasional, Laba Bersih
- Nilai revenue untuk Qiagen N.V. per 2025 Jun 30 adalah 2,040.07 MM.
- Nilai operating income untuk Qiagen N.V. per 2025 Jun 30 adalah 821.83 MM.
- Nilai net income untuk Qiagen N.V. per 2025 Jun 30 adalah 373.39 MM.
Period End (TTM) | Revenue (MM) | Operating Income (MM) | Net Income (MM) |
2025-06-30 | 2,040.07 | 821.83 | 373.39 |
2025-03-31 | 2,002.87 | 523.19 | 93.68 |
2024-12-31 | 1,978.21 | 494.96 | 83.59 |
2024-09-30 | 1,966.17 | 471.97 | 92.93 |
2024-06-30 | 1,940.20 | 166.58 | 72.69 |
2024-03-31 | 1,938.71 | 440.97 | 336.94 |
2023-12-31 | 1,965.31 | 445.25 | 341.30 |
2023-09-30 | 1,954.13 | 436.77 | 332.48 |
2023-06-30 | 1,977.87 | 453.45 | 337.06 |
2023-03-31 | 1,998.53 | 466.32 | 352.93 |
2022-12-31 | 2,141.52 | 576.62 | 423.21 |
2022-09-30 | 2,225.93 | 646.98 | 488.01 |
2022-06-30 | 2,261.05 | 664.37 | 538.75 |
2022-03-31 | 2,312.84 | 707.77 | 563.14 |
2021-12-31 | 2,251.66 | 657.85 | 512.60 |
2021-09-30 | 2,240.49 | 657.74 | 310.55 |
2021-06-30 | 2,189.51 | 658.39 | 479.87 |
2021-03-31 | 2,065.45 | 627.97 | 448.58 |
2020-12-31 | 1,870.35 | 537.47 | 359.19 |
2020-09-30 | 1,712.58 | 459.10 | 191.44 |
2020-06-30 | |||
2020-03-31 |
Laporan Laba Rugi: EPS
Period End (TTM) | Earnings Per Share Basic | Earnings Per Share Diluted |
2025-06-30 | ||
2025-03-31 | ||
2024-12-31 | 0.37 | |
2024-09-30 | 0.43 | 0.43 |
2024-06-30 | 0.34 | 0.34 |
2024-03-31 | 1.56 | 1.55 |
2023-12-31 | 1.59 | 1.57 |
2023-09-30 | 1.55 | 1.54 |
2023-06-30 | 1.57 | 1.56 |
2023-03-31 | 1.64 | 1.63 |
2022-12-31 | 1.97 | 1.95 |
2022-09-30 | 2.28 | 2.24 |
2022-06-30 | 2.51 | 2.46 |
2022-03-31 | 2.62 | 2.57 |
2021-12-31 | 2.38 | 2.34 |
2021-09-30 | 1.44 | 1.40 |
2021-06-30 | 2.23 | 2.17 |
2021-03-31 | 2.08 | 2.03 |
2020-12-31 | 1.67 | 1.62 |
2020-09-30 | 0.89 | 0.88 |
2020-06-30 | 0.06 | 0.07 |
2020-03-31 | -0.15 | -0.15 |
Arus Kas: Operasi, Investasi, Pendanaan
- Nilai cash from operating activities untuk Qiagen N.V. per 2025 Jun 30 adalah 675.03 MM.
- Nilai cash from investing activities untuk Qiagen N.V. per 2025 Jun 30 adalah -159.74 MM.
- Nilai kas dari aktivitas pendanaan untuk Qiagen N.V. per 2025 Jun 30 adalah -318.12 MM.
Period End (TTM) | Cash From Operating Activities (MM) | Cash From Investing Activities (MM) | Cash From Financing Activities (MM) |
2025-06-30 | 675.03 | -159.74 | -318.12 |
2025-03-31 | 680.21 | -135.58 | -417.51 |
2024-12-31 | 673.55 | -249.23 | -422.90 |
2024-09-30 | 633.41 | -300.90 | 58.64 |
2024-06-30 | 575.75 | 178.51 | -828.00 |
2024-03-31 | 520.61 | 352.62 | -716.09 |
2023-12-31 | 459.45 | -87.66 | -433.83 |
2023-09-30 | 432.41 | -153.73 | -972.76 |
2023-06-30 | 519.30 | -446.54 | -163.65 |
2023-03-31 | 579.78 | -854.36 | -124.97 |
2022-12-31 | 715.26 | -726.76 | -125.80 |
2022-09-30 | 826.39 | -516.22 | 362.17 |
2022-06-30 | 770.33 | -690.81 | -121.77 |
2022-03-31 | 754.77 | -623.93 | -147.60 |
2021-12-31 | 639.00 | -202.43 | -150.37 |
2021-09-30 | 744.72 | -362.23 | -236.51 |
2021-06-30 | 592.24 | -455.07 | -77.21 |
2021-03-31 | 570.52 | -350.43 | -100.36 |
2020-12-31 | 457.81 | -443.28 | -50.13 |
2020-09-30 | 297.52 | -469.49 | -60.04 |
2020-06-30 | |||
2020-03-31 |
Metrik Penilaian: PE, PriceToBook, PriceToTBV
- P/Book
- The current closing price divided by the book value per share.
- P/TBV
- The current price divided by the tangible book value per share.
Period End (TTM) | p/e | P/Book | P/TBV |
2025-06-30 | |||
2025-03-31 | |||
2024-12-31 | |||
2024-09-30 | |||
2024-06-30 | |||
2024-03-31 | |||
2023-12-31 | |||
2023-09-30 | |||
2023-06-30 | |||
2023-03-31 | |||
2022-12-31 | |||
2022-09-30 | |||
2022-06-30 | |||
2022-03-31 | |||
2021-12-31 | |||
2021-09-30 | |||
2021-06-30 | |||
2021-03-31 | |||
2020-12-31 | |||
2020-09-30 | |||
2020-06-30 | |||
2020-03-31 |
Metrik Penilaian: EBitToEv, EBit3YrAvgToEv
Period End (TTM) | EBIT/EV | EBIT (3y)/EV |
2025-06-30 | ||
2025-03-31 | ||
2024-12-31 | ||
2024-09-30 | ||
2024-06-30 | ||
2024-03-31 | ||
2023-12-31 | ||
2023-09-30 | ||
2023-06-30 | ||
2023-03-31 | ||
2022-12-31 | ||
2022-09-30 | ||
2022-06-30 | ||
2022-03-31 | ||
2021-12-31 | ||
2021-09-30 | ||
2021-06-30 | ||
2021-03-31 | ||
2020-12-31 | ||
2020-09-30 | ||
2020-06-30 | ||
2020-03-31 |
Efektivitas Manajemen
- roa untuk Qiagen N.V. pada 2025 Jun 30 adalah 0.02.
- roe untuk Qiagen N.V. pada 2025 Jun 30 adalah 0.11.
- roic untuk Qiagen N.V. pada 2025 Jun 30 adalah 0.02.
- croic untuk Qiagen N.V. pada 2025 Jun 30 adalah 0.03.
- ocroic untuk Qiagen N.V. pada 2025 Jun 30 adalah 0.14.
Period End (TTM) | ROA | ROE | ROIC (Tingkat Pengembalian Investasi Modal) | CROIC | OCROIC |
2025-06-30 | 0.02 | 0.11 | 0.02 | 0.03 | 0.14 |
2025-03-31 | 0.01 | 0.03 | 0.02 | -0.00 | 0.14 |
2024-12-31 | 0.01 | 0.02 | 0.02 | -0.00 | 0.14 |
2024-09-30 | 0.02 | 0.03 | 0.02 | 0.07 | 0.12 |
2024-06-30 | 0.05 | 0.09 | 0.06 | 0.03 | 0.10 |
2024-03-31 | 0.05 | 0.10 | 0.06 | -0.01 | 0.08 |
2023-12-31 | 0.07 | 0.15 | 0.09 | -0.13 | 0.09 |
2023-09-30 | 0.08 | 0.15 | 0.09 | -0.02 | 0.10 |
2023-06-30 | 0.08 | 0.15 | 0.09 | -0.02 | 0.10 |
2023-03-31 | 0.07 | 0.16 | 0.09 | -0.07 | 0.11 |
2022-12-31 | 0.07 | 0.14 | 0.08 | -0.03 | 0.13 |
2022-09-30 | 0.09 | 0.15 | 0.09 | 0.12 | 0.15 |
2022-06-30 | 0.09 | 0.17 | 0.10 | -0.01 | 0.14 |
2022-03-31 | 0.09 | 0.19 | 0.10 | -0.00 | 0.14 |
2021-12-31 | 0.10 | 0.18 | 0.10 | 0.06 | 0.14 |
2021-09-30 | 0.10 | 0.22 | 0.12 | 0.03 | 0.12 |
2021-06-30 | 0.09 | 0.20 | 0.10 | 0.01 | 0.12 |
2021-03-31 | 0.09 | 0.18 | 0.09 | 0.03 | 0.11 |
2020-12-31 | 0.07 | 0.14 | 0.07 | -0.01 | 0.09 |
2020-09-30 | 0.04 | 0.08 | 0.04 | -0.05 | 0.06 |
2020-06-30 | 0.00 | 0.01 | 0.00 | 0.02 | 0.09 |
2020-03-31 | -0.01 | -0.01 | -0.01 | 0.03 | 0.07 |
Gross Margins
- marjin kotor untuk Qiagen N.V. pada 2025 Jun 30 adalah 0.67.
- marjin bersih untuk Qiagen N.V. pada 2025 Jun 30 adalah 0.05.
- marjin operasi untuk Qiagen N.V. pada 2025 Jun 30 adalah 0.26.
- Margin Kotor
- The Gross Margin is the ratio of revenue left after substracting the Cost of Goods Sold. It is calculated as 1.0 - (Revenue - COGS ) / Revenue.
- Margin Keuntungan Bersih
- Margin Bersih (juga dikenal sebagai Margin Keuntungan) adalah rasio pendapatan yang tersisa setelah dikurangi Pendapatan Bersih. Perhitungannya adalah Pendapatan Bersih / Pendapatan.
- Margin Operasi
- Margin Operasi adalah rasio pendapatan yang tersisa setelah dikurangi Pendapatan Operasi. Perhitungannya adalah Pendapatan Operasi / Pendapatan.
Period End (TTM) | Margin Kotor | Margin Keuntungan Bersih | Margin Operasi |
2025-06-30 | 0.67 | 0.05 | 0.26 |
2025-03-31 | 0.67 | 0.04 | 0.25 |
2024-12-31 | 0.67 | 0.04 | 0.25 |
2024-09-30 | 0.66 | 0.05 | 0.24 |
2024-06-30 | 0.66 | 0.17 | 0.23 |
2024-03-31 | 0.66 | 0.17 | 0.23 |
2023-12-31 | 0.66 | 0.25 | 0.23 |
2023-09-30 | 0.66 | 0.25 | 0.23 |
2023-06-30 | 0.67 | 0.25 | 0.23 |
2023-03-31 | 0.68 | 0.25 | 0.24 |
2022-12-31 | 0.68 | 0.20 | 0.27 |
2022-09-30 | 0.67 | 0.21 | 0.29 |
2022-06-30 | 0.67 | 0.23 | 0.29 |
2022-03-31 | 0.68 | 0.23 | 0.30 |
2021-12-31 | 0.68 | 0.23 | 0.30 |
2021-09-30 | 0.69 | 0.27 | 0.29 |
2021-06-30 | 0.69 | 0.22 | 0.30 |
2021-03-31 | 0.69 | 0.22 | 0.30 |
2020-12-31 | 0.70 | 0.19 | 0.29 |
2020-09-30 | 0.70 | 0.11 | 0.27 |
2020-06-30 | 0.71 | 0.01 | 0.24 |
2020-03-31 | 0.70 | -0.02 | 0.19 |
Pengenal dan Deskriptor
Kunci Indeks Pusat (CIK) | 1015820 |
Grupong Pang-industriya
SIC 2836 - Biological Products, Except Diagnostic Substances (Biotech) |